Jul 16, 2025 04:01PM
Jul 16, 2025 04:01PM
Jul 15, 2025 09:10AM
Jul 15, 2025 09:10AM
May 8, 2024 07:59AM
Apr 3, 2024 07:58AM
Apr 3, 2024 07:58AM 60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis
Feb 8, 2024 07:59AM
Feb 8, 2024 07:59AM
Jan 31, 2024 11:15AM
Jan 30, 2024 09:01AM
Jan 30, 2024 09:00AM
Jan 22, 2024 07:59AM
Jan 22, 2024 07:59AM 60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
Jan 16, 2024 07:59AM
Jan 16, 2024 07:59AM
Dec 26, 2023 07:59AM
Dec 26, 2023 07:59AM
Nov 15, 2023 07:29AM
Nov 15, 2023 07:29AM
Oct 19, 2023 08:31AM 60 Degrees Pharma to Present Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting in Boston
Oct 12, 2023 04:16PM
Oct 12, 2023 04:16PM
Aug 22, 2023 07:32AM
Aug 22, 2023 07:31AM
Aug 15, 2023 07:31AM
Aug 15, 2023 07:31AM
Jul 31, 2023 07:59AM 60 Degrees Pharmaceuticals (SXTP) Awarded Canadian Patent Covering Tafenoquine
Jul 31, 2023 07:59AM
Jul 14, 2023 01:30PM
Jul 14, 2023 12:39PM
Jul 12, 2023 01:45PM
Jul 12, 2023 01:45PM
Jul 12, 2023 12:29PM

66,630 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All